146
Participants
Start Date
December 7, 2017
Primary Completion Date
December 22, 2022
Study Completion Date
December 22, 2022
next-generation sequencing (NGS)
ESR1, PI3KCA and AKT extensive exon sequencing will be performed using NGS (Miseq Illumina) at the Biopathology department, Institut de Cancérologie de Lorraine (ISO15189 certified lab). Samples taken at baseline (t0), at progression (tp) and 3 months before progression (tp-3) will be systematically analyzed. The intermediate samples will be stored and kept for additional studies. Follow up assessment will be performed according to prescriber's directions.
Institut Jean Godinot, Reims
Polyclinique de Courlancy, Reims
Institut de cancérologie de Lorraine, Vandœuvre-lès-Nancy
Hôpital Claude Bernard, Metz
CHR Metz-Thionville, Metz
Polyclinique de l'Orangerie, Strasbourg
Clinique Saint Anne, Strasbourg
CHU Strasbourg, Strasbourg
Centre Henri Becquerel, Rouen
Centre d'oncologie Gentilly, Nancy
Institut de Cancérologie de Lorraine
OTHER